EPA ethyl ester dosing lowers cardiovascular event risk in statin-treated patients without raising LDL-C or non-HDL-C levels.
A mixed amorphous-crystalline curcumin composition improves solubility, pH stability, and oral bioavailability for osteoarthritis support.